Contineum Therapeutics, Inc. Class A Common Stock Share Price
NASDAQ: CTNMHealthcare
Live Contineum Therapeutics, Inc. Class A Common Stock Share Price Chart
O H L
Contineum Therapeutics, Inc. Class A Common Stock Performance Overview
Days Range
▼
$13.47Low
$13.71High
Markets Today
| Previous Close | $13.21 |
|---|---|
| Open | $13.47 |
| Volume | 85,767 |
| Day's Range | $13.47 - $13.71 |
| 52W Range | $8.60 - $17.79 |
| Market Cap | $517.67 M |
Historical Performance
| 1M Returns | -8.90 |
|---|---|
| 3M Returns | +10.64 |
| 6M Returns | +8.10 |
| 1Y Returns | +6.53 |
| 5Y Returns | NA |
| 10Y Returns | NA |
Contineum Therapeutics, Inc. Class A Common Stock Fundamentals
| Market Cap | $517.67 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.26 |
| EPS TTM | $-1.74 |
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.16 |
| EBITDA | $-67.74 M |
| Profit Margin | N/A |
| Market Cap | $517.67 M |
|---|---|
| Dividend yield | 0.00 |
| PE Ratio | 0.00 |
| PEG Ratio | N/A |
| Revenue | $0.00 |
| ROE TTM | -0.26 |
| EPS TTM | $-1.74 |
|---|---|
| Quarterly Earnings Growth YOY | N/A |
| PB Ratio | 2.16 |
| EBITDA | $-67.74 M |
| Profit Margin | N/A |
Contineum Therapeutics, Inc. Class A Common Stock Profit & Loss
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Total Revenue + | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross Profit + | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating Income | -$18.11 M | -$17.90 M | -$14.93 M | -$17.11 M | -$16.90 M | -$17.43 M |
| EBITDA | -$18.03 M | -$17.82 M | -$14.85 M | -$17.03 M | -$16.82 M | -$17.29 M |
| Interest Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Depreciation | $78.00 K | $79.00 K | $81.00 K | $85.00 K | $83.00 K | $134.00 K |
| Income Before Tax | -$15.99 M | -$16.04 M | -$12.79 M | -$15.16 M | -$14.46 M | -$15.15 M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income + | -$15.99 M | -$16.04 M | -$12.79 M | -$15.16 M | -$14.46 M | -$15.15 M |
| Net Profit Margin | - | - | - | - | - | - |
Contineum Therapeutics, Inc. Class A Common Stock Financials Balance Sheet In USD
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Share Capital | $26.00 K | $26.00 K | $29.00 K | $37.00 K | $37.00 K | $38.00 K |
| Reserve & Surplus | -$133.22 M | -$149.28 M | -$161.96 M | -$177.12 M | -$192.09 M | -$207.56 M |
| Non-Current Liabilities | $4.55 M | $4.28 M | $4.02 M | $5.91 M | $4.65 M | $4.18 M |
| Current Liabilities | $8.95 M | $7.21 M | $6.36 M | $9.74 M | $6.66 M | $6.53 M |
| Total Liabilities | $13.50 M | $11.50 M | $10.38 M | $15.65 M | $11.31 M | $10.71 M |
| Fixed Assets | $891.00 K | $856.00 K | $880.00 K | $830.00 K | $1.06 M | $929.00 K |
| Current Assets | $192.13 M | $176.84 M | $184.93 M | $267.92 M | $252.96 M | $242.58 M |
| Total Assets | $198.26 M | $182.89 M | $190.85 M | $276.64 M | $261.35 M | $250.37 M |
Contineum Therapeutics, Inc. Class A Common Stock Cash Flow
Quarterly
| Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|
| Net Income | -$15.99 M | -$16.04 M | -$12.79 M | -$15.16 M | -$14.46 M | -$15.15 M |
| Operating Cash Flow | -$14.41 M | -$15.66 M | -$12.20 M | -$13.04 M | -$16.27 M | -$11.50 M |
| Investing Cash Flow | $14.91 M | $13.88 M | $14.94 M | -$47.45 M | -$39.31 M | $4.85 M |
| Financing Cash Flow | $24.00 K | $91.00 K | $19.11 M | $93.47 M | $129.00 K | $1.20 M |
| Change in Cash | $527.00 K | -$1.69 M | $21.85 M | $32.97 M | -$55.45 M | -$5.45 M |
Contineum Therapeutics, Inc. Class A Common Stock Return Calculator
The Contineum Therapeutics, Inc. Class A Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Returns Estimator
Based on past performance of this fund
ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$10,000
Invested Amount$10,000
Est. Returns$0
About Contineum Therapeutics, Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the development of oral small-molecule therapies for neurological, inflammatory, and immunological conditions. The company focuses on developing selective compounds targeting challenging molecular pathways and has built a portfolio of small molecule drug candidates. Its pipeline includes drug candidates in clinical development, such as PIPE-791, an LPA1 receptor antagonist being studied for idiopathic pulmonary fibrosis and chronic pain, and PIPE-307, an M1 receptor inhibitor being evaluated for relapsing-remitting multiple sclerosis and other depressive disorders.
Popular Stocks
FAQs
What is the share price of Contineum Therapeutics, Inc. Class A Common Stock today?
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) share price as of September 18, 2026 is $13.54. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Contineum Therapeutics, Inc. Class A Common Stock?
Yes, Indian Investors can invest in the Contineum Therapeutics, Inc. Class A Common Stock (CTNM) Share by opening an international trading account with Angel One.
How can I purchase Contineum Therapeutics, Inc. Class A Common Stock shares in India?
Purchasing Contineum Therapeutics, Inc. Class A Common Stock (CTNM) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Contineum Therapeutics, Inc. Class A Common Stock (CTNM) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Contineum Therapeutics, Inc. Class A Common Stock?
Yes, you can purchase fractional shares of Contineum Therapeutics, Inc. Class A Common Stock (CTNM) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Contineum Therapeutics, Inc. Class A Common Stock?
The market capitalization of Contineum Therapeutics, Inc. Class A Common Stock on September 18, 2026, is $517.67 M.
In which sector Contineum Therapeutics, Inc. Class A Common Stock belongs?
Contineum Therapeutics, Inc. Class A Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
What documents are required to invest in Contineum Therapeutics, Inc. Class A Common Stock stocks?
In order to invest in Contineum Therapeutics, Inc. Class A Common Stock (CTNM) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
Diversify Your Portfolio with US Stocks
Invest in Wall Street Giants from India
